STUDY SEARCH RESULTS

1 study found for your search request:  1242-036

Efficacy, safety, and pharmacokinetics of vericiguat in pediatric participants with heart failure du...
Condition: Heart Failure, Left Ventricular Systolic Dysfunction
Minimum Age: 29 days, Maximum Age: 17 years
Gender: All
Study ID: NCT05714085
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site